Clinical Trial Update: A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia [Phase 3]

View source ↗

Summary

Phase III randomized trial evaluating aspirin plus esomeprazole for chemoprevention in Barrett's esophagus. The study has completed and results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Cancer

Drugs mentioned

• Aspirin (Aspirin)
• Esomeprazole (Esomeprazole)

Snippet

Sponsor: University of Oxford | Conditions: Esophageal Cancer, Precancerous Condition | Phase 3 | Status: COMPLETED | Results posted: 2025-05-01